methamphetamine has been researched along with epidermal growth factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malta, RS; Mizuno, M; Nagano, T; Nawa, H | 1 |
| Baes, M; Juri, C; Rubio, FJ; Somoza, R; Wyneken, U | 1 |
2 other study(ies) available for methamphetamine and epidermal growth factor
| Article | Year |
|---|---|
Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal period.
Topics: Animals; Animals, Newborn; Cocaine; Conditioning, Psychological; Epidermal Growth Factor; Female; Humans; Methamphetamine; Motor Activity; Rats; Rats, Sprague-Dawley | 2004 |
Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
Topics: Actins; Animals; Brain Injuries; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Proliferation; Cell Survival; Culture Media; Culture Media, Serum-Free; Epidermal Growth Factor; Epigenesis, Genetic; Fibroblast Growth Factor 2; Gene Expression; Humans; Intermediate Filament Proteins; Locomotion; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methamphetamine; Nerve Tissue Proteins; Nestin; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, trkB; Rotation; Substantia Nigra; Tyrosine 3-Monooxygenase | 2010 |